ABSTRACT
Wearing of face coverings serves two purposes: reducing the concentration of ambient particles inhaled and reducing the emission of respiratory particles generated by the wearer. The efficiency of different face coverings depends on the material, design, and fit. Face coverings such as N95 respirators, when worn properly, are highly efficient at filtering ambient particles during inhalation. Some N95 respirators, as well as other face covering types, include a one-way valve to allow easier exhalation while still maintaining high filtration efficiency towards ambient particles. The extent to which these valves decrease filtration of emitted respiratory particles is, however, not well established. Here, we show that different valved N95s exhibit highly variable filtration efficiencies for exhaled respiratory particles. As such, valved N95s do not provide reliable source control of respired particles and their use should be discouraged in situations where such source control is needed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of California Davis Institutional Review Board approved this study, and all research was performed in accordance with relevant guidelines and regulations of the Institutional Review Board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
